Johnson & Johnson Launches Varipulse Pro in Europe with 5× Faster Ablation
Johnson & Johnson launched its CE-marked Varipulse Pro pulsed field ablation system in Europe, featuring a lower temperature profile and five-times faster ablation integrated with the Carto 3 mapping system. It has begun multi-centre VARIPURE postmarket follow-up trials while FDA approved its TECNIS PureSee EDOF intraocular lens.
1. European Varipulse Pro Launch
Johnson & Johnson launched the CE-marked Varipulse Pro pulsed field ablation system in Europe, featuring a new low-temperature pulse sequence with five-times faster ablation times and integration with the Carto 3 System’s advanced mapping and tissue proximity indicators.
2. VARIPURE Postmarket Trial
Initial cases under the multi-centre, prospective VARIPURE postmarket follow-up study have commenced to gather robust clinical evidence during the commercial rollout, with interim 12-month outcomes set for presentation at the EHRA PFA Summit.
3. FDA Approval for TECNIS PureSee Intraocular Lens
Last month the company secured FDA approval for its TECNIS PureSee extended depth of focus intraocular lens for cataract surgeries, with US availability expected later this year.